✦ LIBER ✦

Assessment of Infusional 5-Fluorouracil Schedule and Dose Intensity: A Southwest Oncology Group and Eastern Cooperative Oncology Group Study

✍ Scribed by Cynthia G. Leichman; Jacqueline K. Benedetti; Mark M. Zalupski; Howard Hochster; Anthony F. Shields; Heinz-Josef Lenz; James L. Wade III; James D. Bearden III; John S. Macdonald

Book ID: 119934988
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 483 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2005.n.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathogenetic implications of internuclea

Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An eastern cooperative oncology group/southwest oncology group cooperative study

✍ David R. Head; Kenneth Kopecky; John M. Bennett; Kathy Grenier; Francis S. Morri 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Cyclophosphamide, methotrexate, and 5-fl

Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A southwest oncology group study

✍ Antoinette J. Wozniak; Brent A. Blumenstein; E. David Crawford; Michael Boileau; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 3 views

Effect of schedule on activity and toxic

Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: A southwest oncology group study

✍ J. H. Saiki; G. P. Bodey; J. S. Hewlett; M. Amare; F. S. Morrision; H. E. Wilson 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB 👁 3 views

Evaluation of low dose continuous infusi

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study

✍ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology

Phase II study of cisplatin and 5‐fluoro

Phase II study of cisplatin and 5‐fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185)

✍ Omer Kucuk; Kishan J. Pandya; Roland T. Skeel; Howard Hochster; Martin D. Abelof 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 42 KB

Infusional interleukin-2 and 5-fluoroura

Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-α for the treatment of patients with advanced renal cell carcinoma : A Southwest Oncology Group Phase II study

✍ Laurence Elias; Danika Lew; Robert A. Figlin; Robert C. Flanigan; Mark E. Thomps 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views